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Abstract:  In  an  effort  to  develop  an  implantable  optical  perfusion  and 
oxygenation sensor, based on multiwavelength reflectance pulse oximetry, 
we investigate the effect of source–detector separation and other source-
detector characteristics to optimize the sensor’s signal to background ratio 
using Monte Carlo (MC) based simulations and in vitro phantom studies. 
Separations in the range 0.45 to 1.25 mm were found to be optimal in the 
case of a point source. The numerical aperture (NA) of the source had no 
effect  on  the  collected  signal  while  the  widening  of  the  source  spatial 
profile caused a shift in the optimal source-detector separation. Specifically, 
for a 4.5 mm flat beam and a 2.4 mm × 2.5 mm photodetector, the optimal 
performance was found to be when the source and detector are adjacent to 
each other. These modeling results were confirmed by data collected from 
in  vitro  experiments  on  a  liver  phantom  perfused  with  dye  solutions 
mimicking  the  absorption  properties  of  hemoglobin  for  different 
oxygenation states. 
© 2011 Optical Society of America 
OCIS codes: (170.1470) Blood or tissue constituent monitoring; (170.3660) Light propagation 
in  tissues;  (280.1415)  Biological  sensing  and  sensors;  (300.6340)  Spectroscopy,  infrared; 
(290.1990) Diffusion 
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1. Introduction 
According to the Organ Procurement and Transplantation Network (OPTN) and the Scientific 
Registry of Transplant  Recipients (SRTR), in their 2009 OPTN/SRTR report (Table 1.3), 
between  the  years  1999  and  2008  the  number  of  registrations  on  the  waitlist  for  liver 
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this same period, the number of transplant recipients per year ranged between 4,498 and 6,363 
(their Table 9.4a) [1]. These numbers show a clear need to minimize  graft loss, increase 
chances of transplant success, and  maximize transplant rates. Graft loss is  mainly due to 
ischemia and an implantable sensor that monitors the graft status in the 7 to 14 days period 
post-surgery to ensure adequate perfusion and oxygenation are available to the liver can help 
prevent organ failure. 
Some of the prevailing perfusion monitoring techniques are Doppler based such as laser 
Doppler  flowmetry  (LDF)  [2]  and  Doppler  ultrasound  [3].  These  techniques  measure  the 
Doppler  shift  caused  by  any  moving  objects  to  deduce  flow.  This  leads  to  high  motion 
artifacts making them not suitable for implantable sensors [2]. Another technique widely used 
in  the  clinical  setting  is  thermal  diffusion  [4,5].  This  technique,  originally  introduced  by 
Bowman  et  al.  [6],  measures  tissue  perfusion  based  on  thermal  convection.  A  thermal 
diffusion probe consists of two thermistors, the proximal thermistor is passive and measures 
the baseline temperature of the surrounding tissue while the distal thermistor is active and is 
powered to cause a local increase in temperature (of about 2°C). The power needed to cause 
and sustain this temperature elevation is used to measure blood perfusion to the tissue. A 
typical thermal diffusion probe is around 1 mm in diameter [4,5]. These probes have been 
used in multiple microvascular applications ranging from cerebral blood flow [4] to pedicle 
flaps [5]. They also showed success in ex vivo hepatic perfusion monitoring [7,8]. However, 
although  very  suitable  to  measure  tissue  perfusion,  the  principle  of  thermal  diffusion  is 
difficult  to  apply  directly  on  blood  vessels.  Another  problem  with  both  aforementioned 
techniques is the lack of oxygenation information that is essential in judging the wellbeing of 
the graft. Pulse oximetry is the standard for measuring oxygenation in clinics [9,10]. It is 
based  on  investigating  the  difference  in  the  optical  properties  of  oxygenated  hemoglobin 
(HbO2) and deoxygenated hemoglobin (HbO) using two wavelengths of light on both sides of 
the  hemoglobin  isobestic  point  (805  nm).  Reichelt  et  al.  reported  an  implantable  pulse 
oximeter system [11] for monitoring blood oxygenation and pulse rate in vessels. This sensor 
operates  in  transmission  mode  and  it  was  found  that  this  mode,  with  the  two  selected 
wavelengths (660 and 940 nm) is not suitable for vessels larger than 5 mm in diameter. The 
portal vein, the main blood supplier to the liver [12], is 7.8 +/ 1.5 mm in diameter [13] and 
thus,  such  a  sensor  is  not  suitable  for  monitoring  blood  supply  through  the  portal  vein. 
Moreover, this system does not detect changes in perfusion and is suitable only for monitoring 
blood oxygenation in blood vessels and not in tissue. 
Our  sensor  employs  a  modified  version  of  reflectance  pulse  oximetry  with  an  added 
wavelength at the hemoglobin isobestic point (805 nm) to be used to separate the perfusion 
and oxygenation signals [14–16]. Since the sensor operates on diffuse reflection, it can be 
used to monitor perfusion and oxygenation on both blood vessels and parenchymal tissue. 
Multiple sensors at the input vessels and the parenchymal tissue will help identify oxygen 
consumption, blood perfusion and perfusion homogeneity in the liver which are the three 
parameters  needed  to  detect  ischemia.  The  sensor  employs  three,  time  multiplexed,  light 
emitting  diodes  (735,  805  and  940  nm)  modulated  to  increase  the  signal  to  noise  ratio. 
Although our focus is to use this sensor to monitor perfusion and oxygenation to the liver 
post-transplant, this sensor can be used to monitor perfusion and oxygenation to most visceral 
organs. 
The  performance  of  sensors  based  on  diffuse  reflection  has  been  shown  to  be  highly 
dependent on the probe design and especially on the source to detector separation [17–21]. In 
this work, we investigate the effect of the source to detector separation on the performance of 
the previously mentioned sensor through Monte Carlo modeling and in vitro phantom studies. 
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2.1. Monte Carlo simulations 
A multilayer photon propagation Monte Carlo simulation program based on the algorithm 
developed by Wang et al. [22] was developed in MATLAB. The placement of the sensor on 
the portal vein, the main blood supplier to the liver [12], and the hepatic artery were modeled 
as three layer structures (Fig. 1). The first and third layer have the optical properties of liver 
tissue [23] and the middle layer has the optical properties of whole blood and the dimensions 
of the vessel under investigation (Table 1). The optical properties of blood were changed to 
mimic different oxygenation states [24,25]. Table 2 shows the optical properties of the two 
oxygenation states of blood at the three wavelengths of interest [25,26]. 
Table 1. Diameter and wall thickness of the portal vein [13,27] and hepatic artery [13,28] 
   Portal Vein (PV)  Hepatic Artery (HA) 
Vessel wall thickness (mm)  0.61  0.49 
Vessel lumen diameter (mm)  7.8  3.8 
 
Fig. 1. A schematic of the multilayer model mimicking a blood vessel. 
For each run, 1 million photon packets were launched in different directions, with equal 
probability, within the Numerical Aperture (NA) of the source. The program recorded the 
collected  intensity  at  the  tissue  surface  and  the  corresponding  penetration  depth  of  each 
photon collected, producing a photon distribution map indicating at every point of the surface 
how many photons were collected and the penetration depth of each photon. This feature was 
used to find the probing depth for every source to detector separation and to separate the 
background intensity collected from photons that are probing the blood. 
Table 2. Blood optical properties for two oxygenation states [24,25] 
   Oxygenated    Deoxygenated 
λ (nm)  µa (1/mm)  µs (1/mm)  g    µa (1/mm)  µs (1/mm)  g 
735 nm  0.2408  80.5  0.9790   0.6025  80.5  0.9790 
805 nm  0.4557  76.7  0.9786   0.3943  76.7  0.9786 
940 nm  0.6555  67.7  0.9760   0.3744  67.7  0.9760 
To  study  the  effect  of  the  source  spatial  distribution,  the  collected  intensity  was 
convoluted with the source spatial profile as discussed by Wang et al. [29]. All the modeling 
results were verified by comparison to MCML and CONV developed by Wang et al. [22,29]. 
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To verify the modeling results, an in vitro system was constructed to measure perfusion and 
oxygenation in a liver phantom at different source - detector separations. The phantoms were 
designed to imitate the case where the sensor is placed on a blood vessel (PV or HA) at the 
entrance of the liver to monitor the blood supply. 
The polydimethylsiloxane (PDMS) based phantom was prepared by mixing 437.4 mg of 
0.5-1  μm  Al2O3  powder,  120  mg  of  100  nm  Al2O3  powder,  4.02μL  of  black  India  ink 
(Higgins, Black India 4415), 120 μL of blue food coloring, and 60mL PDMS resin. Long et 
al. showed that this formula has similar optical properties to liver tissue [30]. The mixture was 
sonicated and stirred until homogeneously distributed. Then, 6 mL of curing agent was added 
to the mixture and stirred until uniform. Vacuum was applied to degas bubbles in the mixture. 
Finally, the mixture was poured into a petri-dish containing a plastic tube (8 mm in outer 
diameter for the PV or 3 mm for HA) fixed at 1 mm above the petri-dish bottom surface and 
cured at 65°C to completely crosslink the PDMS. The plastic tube was removed, and the 
resulting phantom is a slab with the optical properties of liver tissue containing a hollow 
cylindrical structure with similar dimensions to the vessel under investigation (PV or HA). 
Slabs of the same material were also fabricated for use in case extra thickness above or below 
the initial design is needed. Figure 2 shows a schematic of the phantom with the optical probe 
placed on top of it. 
 
Fig. 2. A schematic of the PDMS based portal vein phantom showing the placement of the 
probe on top. The Light Emitting Diode is protruding out of the probe surface to provide better 
light coupling to the interrogation medium. The source to detector separation is referred to as d. 
To  avoid  handling  whole  blood  that  needs  to  be  in  a  pH  and  temperature  controlled 
medium, and requires oxygenators and blood analyzers to change and test oxygen levels, we 
formulated two dye solutions that have optical properties similar to circulating blood in its 
oxygenated and deoxygenated states [25,26]. To mimic the absorption spectrum of  whole 
blood in its deoxygenated state, we used a mixture of 0.165% v/v India ink (Speedball Art, 
product  number  3338)  and  2.67%  v/v  inkjet  photo  cyan  (Macro  Enter,  cat.#  FPB085) 
dissolved  in  Phosphate  Buffered  Solution  (PBS  0.01M,  pH  7.4).  The  India  ink  has  an 
extinction coefficient that covers all the wavelength bands of interest [31,32] and it was used 
to create a baseline in the extinction coefficient spectrum that matches the absorption in the 
near infrared wavelength range. The inkjet photo cyan was used to increase the absorption on 
the red side of the spectrum, a characteristic of the deoxygenated state of blood. On the other 
hand, the oxygenated state has a higher absorption in the NIR region and 188.6 mg/L of 
Epolight 2717 (Epolin, Inc.) was used to increase the absorption in the NIR region along with 
0.088%  v/v  of  India  ink  in  a  PBS.  The  extinction  coefficient  of  the  two  dye  solutions 
compared to that of whole blood is shown in Fig. 3. 
The extinction coefficient of the dye solutions matches closely to that of whole blood at 
the three wavelengths of interest (735, 805 and 940 nm). The isobestic point is red shifted 
when compared to the data reported by Prahl [25], however, there are inconsistencies in the 
reported isobestic point between different groups and it ranges between 797 nm [25] and 815  
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Fig. 3. A comparison of the absorption spectra of whole blood and the two dye solutions used 
in the in vitro setup. M1 is the dye mixture mimicking oxygenated blood and is made of 
Epolight 2717 and India ink. M2 is made of India ink and inkjet photo cyan to mimic the 
optical properties of deoxygenated blood. The solid lines show the extinction coefficients of 
the two oxygenation states of whole blood [25,26]. 
nm [33]. Our dye mixtures have an isobestic point, at 807 nm, in between these two extremes. 
At 735 nm the extinction coefficient of the dye solution M1 does not match exactly that of the 
oxygenated state of circulating blood. This causes the dynamic range between the two dye 
solutions at 735 nm to decrease causing the resolution in detecting oxygenation changes to 
decrease. For the purpose of this paper, this is not problematic since the main goal is to 
determine the optimal probe design and the same dye solution will be used to compare all of 
the different designs. At 940 nm, the two solutions match the desired extinction coefficients 
exactly. 
Two peristaltic pumps (Gilson, Minipuls 3) driven using LabVIEW via a data acquisition 
board (National Instruments, USB 6009) were used to pump the dye solutions through the 
phantom. Extra care was taken to ensure no air bubbles were circulated. The driver signal 
used to control the pumps was a square wave. The frequency and the pulse width were set to 
the desired values that mimic the cardiac pulsatile flow pattern. Each pump can be used to 
pump a different dye solution corresponding to different oxygenation states and the mixture 
can mimic any oxygenation state by changing the ratio of the pump speeds. 
The probes used are circular (1 inch in diameter) and contain a single can package with 
four light emitting diodes (epitex, L660/735/805/940-40B42-C-I) and a silicon photodetector  
 
 
Fig. 4. In vitro setup showing the two peristaltic pumps pushing a dye solution through the PV 
phantom with the optical probe held on top with a mechanical arm. Note the phantom appears 
light bluish in color to the eye but has the optical properties, in the 735-940 nm wavelength 
range, of liver. 
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from 2 mm to 10 mm (edge to edge separation) with a step of 2 mm. A mechanical arm was 
used to fix the probe on the surface of the phantom above the hollow cylinder (Fig. 2) with the 
LED and photodetector aligned along the tube. The three wavelengths are time multiplexed to 
minimize power consumption and prevent overlap of the optical signal at the photodetector 
[14]. Figure 4 shows the complete setup with the LabVIEW interface used for data collection 
and visualization. 
3. Results 
3.1. Monte Carlo modeling results 
The diffuse reflection intensity at the surface decayed rapidly with increasing source-detector 
separation  for  all  three  wavelengths,  for  both  simulated  oxygenated  and  de-oxygenated 
signals. However, these intensities (the case of oxygenated blood is shown in Fig. 5a) carry 
signal from the blood volume as well as background intensity from the surrounding tissue. To 
separate  the  signal  from  background  intensity,  we  looked  at  the  difference  between  the 
collected  intensity  in  the  cases  of  oxygenated  and  deoxygenated  blood.  This  difference 
eliminates the constant background intensity and is a better indicator of the optimal spacing to 
collect the highest signal probing the blood volume. The difference showed a plateau phase 
followed by a quick decay for the 735 and 940 nm wavelengths. This plateau extends to 0.55 
and 0.45 mm for the 735 and 940 nm wavelengths respectively (Fig. 5b). However, the 805 
nm  wavelength,  since  it  is  near  the  isobestic  point,  carried  little  information  about  the 
oxygenation state. Note that the 805 nm wavelength does have a little bias to the 940 nm side, 
since  in  our  model  805  nm  is  on  the  IR  side  of  the  isobestic  point.  After  the  peak,  the 
difference signal decayed rapidly to reach 10% of its maximal value at 2.4 and 2.2 mm for the 
735 and 940 nm wavelengths respectively. Despite the rapid decay, there was still a relatively 
long range where the signal is strong enough to have a dynamic difference between the two 
oxygenation states. 
In Fig. 5 the signal is presented in terms of its total reflectance at a specific distance (Fig. 
5a  for  oxygenated  simulation)  and  difference  between  oxygenated  and  de-oxygenated 
reflectance (Fig. 5b). However, the overall intensity decays with increasing separation. This 
implies that, although signal (S) is decaying, the signal to background ratio (SBR) might be 
constant or even increasing. To validate this hypothesis, we looked at the normalized intensity 
that we defined as the ratio of signal difference (S) to the total average intensity (It). Equation 
(1) shows the defined SBR ratio where Roxy and RDeoxy are the photon fluence at the surface in 
the oxygenated and deoxygenated state respectively. 
  .
0.5 ( )
Oxy Deoxy
Oxy Deoxy t
RR S
SBR
R R I



   (1) 
S is the signal defined as the difference between the collected intensities in the oxygenated 
and deoxygenated states:  Oxy Deoxy S R R   
It is the average total intensity in the oxygenated and deoxygenated states: 
  .
2
Oxy Deoxy
t
RR
I

    
Note that It is the average total intensity; thus it comprises both signal and background and the 
defined SBR is the ratio of the difference signal to the total collected intensity which gives an 
idea about the signal to background ratio. 
#147375 - $15.00 USD Received 12 May 2011; revised 27 Jun 2011; accepted 28 Jun 2011; published 29 Jun 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2102 
Fig. 5. Left panel; Fluence decay curves for all three wavelengths as a function source to 
detector separation. These curves correspond to the case of oxygenated blood. The curves 
indicate a rapid decay in total collected fluence with increasing separation. Right panel: the 
difference (S = ROXY – RDEOXY) as a function of source to detector separation. The signal S 
shows a plateau phase with a maximal value followed by a rapid decay for the 735 and 940 nm 
wavelengths. The 805 nm wavelength carries a low oxygenation signal since it was slightly on 
the IR side of the isobestic point. The arrows indicate the end of the plateau phase and the start 
of the rapid decay. 
 
Fig. 6. SBR as a function of source to detector separation. SBR starts from 0 and absolute value 
increases  monotonically  (Note  by  definition  this  means  at  735  nm  the  SBR  is  positively 
increasing and at 940 nm the SBR is negatively increasing with separation indicating a decrease 
in the background to signal ratio. For the 805 nm wavelength, SBR is close to zero with a little 
bias to the negatively increasing 940 nm side, since in our model 805 nm is on the IR side of 
the isobestic point. 
Figure 6 shows the SBR calculated using (1) as a function of source-detector separation. In 
the source-detector separation range shown (0.05 to 10 mm) the absolute value of the SBR is 
monotonically increasing. Past this range, this ratio is very noisy due to the weakness of the 
collected intensity. 
To better understand this phenomenon, we added to our MC algorithm a feature to record 
the penetration depth of the collected photons on the tissue surface. As shown in Fig. 7(a) 
below, although the total intensity decreased, the ratio of photons collected from the vessel 
lumen (deeper than 0.5 mm which is the vessel upper limit) increased relatively to the photons 
probing the shallow tissue as we increased the source to detector separation. However, the 
total number of collected photons probing the blood layer decreased. This supports the data 
presented  in  Figs.  5  and  6  and  indicates  that  the  total  intensity  and  signal  decrease  with 
increasing source to detector separations but the signal to background ratio increases. These 
findings are very important to know when designing probes for this type of sensor in order to 
optimize the use of the dynamic range of the photodetector as discussed in further details in 
Section 4. 
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Fig. 7. The distribution of the collected photon fluence on the penetration depth for the 735 nm 
wavelength. Photons with a penetration depth higher than 0.5 mm are considered as signal 
while those that have a shallower penetration depth are considered as background since they do 
not  probe  the  blood  volume.  Panel  (a)  shows  the  data  for  5  selected  source-detector 
separations. Panel (b) is a 3D representation of the data. 
Figure 7(b) shows the collected photon fluence as a function of separation and penetration 
depth  of  each  photon.  This  figure  shows  two  peaks  before  and  after  the  vessel  lumen 
boundary  at  0.5  mm.  The  shallower  peak  corresponds  to  the  background  intensity  and, 
although higher in intensity, decays (as a function of source to detector separation) faster than 
the second peak that corresponds to the signal collected from the vessel lumen. The axes on 
this graph start at 0.2 mm (depth) and 0.1 mm (source to detector separation) because before 
these points there is a high background peak (at 0.1 mm depth and 0.1 mm source to detector 
separation) that is difficult to visualize with the signal peak on the same scale. 
One way to maximize both quantities, SBR and S, if weighted equally is to maximize their 
product (Eq. (2)). Figure 8 shows the product as a function of source-detector separation. 
   
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RR

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
   (2) 
As expected, the 805 nm wavelength carries almost no oxygenation information and the 
product is stable at nearly zero for all spacings. However, for both the 735 and 940 nm 
wavelengths, the product starts as an increasing function with source to detector separation 
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around 1.25 and 1.35 mm, respectively. 
 
Fig. 8. The product of signal (S) and SBR as a function of source to detector separation. The 
product  shows  a  plateau  phase  with  maximal  S*SBR  product  for  the  735  and  940  nm 
wavelengths. The 805 nm wavelength carries almost no oxygenation signal and the product is 
stable at nearly zero. 
 
Fig.  9.  The  quantities  discussed  earlier  for  a  4.5  mm  source  and  a  2.4  mm  x  2.5  mm 
photodetector.  The  diffuse  reflectance  for  all  three  wavelengths  was  normalized  to  the 
reflectance at the closest separation for the 735 nm wavelength. The signal S was normalized 
similarly. 
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a 
      Point Source     4.5 mm Beam 
      Maximum  Plateau Phase     Maximum  Plateau Phase 
735 nm 
S  0  0–0.55 mm     0  x 
SBR  ↗  > 3.05 mm     ↗  x 
S*SBR  0.55  0.35–1.25 mm     0  x 
940 nm 
S  0  0–0.45 mm     0  x 
SBR  ↗  > 2.55mm     ↗  x 
S*SBR  0.85  0.45–1.35 mm     0  x 
a↗ refers to a monotonically increasing function with increasing source-detector separation. The plateau phase refers 
to ranges of source-detector separations where the corresponding function is changing relatively slow compared to 
the rest of the source-detector separations. 
All  the  previous  results  were  based  on  a  collimated  point  source.  Other  probe 
characteristics such as the source NA and spatial profile might have a significant influence on 
these findings. The NA effect was studied by launching the photons in different directions, 
with equal probability, within a cone corresponding to a numerical aperture specified by the 
user. As expected, the numerical aperture of the source had no significant effect on the results 
because of the highly scattering nature of tissue. 
To investigate the effect of the source spatial profile, we compared the results of the point 
source to those of a 4.5 mm cylindrical flat beam mimicking the light emitting diodes used in 
our probes (Epitex, L660/735/805/940-40B42-C-I) and a photodetector with an active area of 
2.4 mm x 2.5 mm (Hamamatsu, S2833-01). Figure 9 shows the corresponding results. 
Similar to the point source case, Fig. 9 shows a rapid decay in the intensity and signal as 
the detector is moved away from the source. The SBR ratio shows also a similar profile to the 
previous case with the main difference being the start point that is not equal to zero in that 
case. This is expected since  the broad source can be considered as an assembly of point 
sources and even when the detector is placed right next to the source there will still be a point 
source at the other end that is far from the detector and is probing deep in the tissue collecting 
signal from the blood vessel lumen. Note that the results from the circular flat beam appear 
less noisy due to the convolution process, used to account for the source spatial profile, which 
eliminates high frequency noise. This can be thought of as having multiple point sources, 
instead of one, launching photons leading to a less noisy diffuse reflectance signal. Table 3 
summarizes the results presented above. 
3.2. In vitro results 
To verify the modeling results and apply them to our system, we used the setup described in 
section 2.2. Five source-detector spacings were used and compared to the model. For each 
run, one of the two dye solutions corresponding to the two oxygenation states of blood, was 
passed  through  the  phantom  using  the  flow  system  previously  described.  We  alternated 
between the dye solutions to calculate the quantities defined in section 3.1 and the phantom 
was washed in between runs by flowing deionized water through the fluidics system. This 
experiment was repeated three times. For each set of experiments, data was collected with the 
shortest spacing probe first and its position on the phantom was marked to guaranty similar 
coupling between all probes. Figure 10 shows the signal S, previously defined in Eq. (1), for 
the in vitro phantom studies compared to the MC modeling results. The data from 3 sets of 
experiments was averaged. In terms of calibration, the average of the shortest spacing probe 
was  normalized  to  the  model  to  account  for  the  probe  characteristics  such  as  detector 
sensitivity and LED power, the same calibration factor was applied to the rest of the probes. 
Since the 805 nm wavelength carries minimal information about changes in the dye solution 
(i.e. simulated oxygenation), it was used as a baseline to account for any changes not related 
to varying the dye solution as shown in Eq. (3). In the ideal case, where there are no changes 
in the background, the intensity on the 805 nm wavelength is the same for both dye solutions 
and Eq. (3) reduces to (IOxy - IDeoxy). In this case, IOxy and IDeoxy are the collected intensity at the 
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oxygenated and deoxygenated blood, respectively: 
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Fig. 10. In vitro data collected from the PDMS based phantom perfused with the dye solutions. 
The solid lines show the data from the MC model while the squares and circles represent the 
average  of  the  collected  data  from  the  phantom  at  the  735  and  940  nm  wavelengths 
respectively. The error bars correspond to  one standard deviation. 
4. Discussion 
The  probing  depth  in  diffuse  reflection  is  highly  dependent  on  the  source  to  detector 
separation. Large separations lead to deeper probing which increases the blood signal carrying 
portion of the total intensity. However, this increases the optical path length and attenuates the 
total intensity causing lower levels of light to be collected which leads to higher system error. 
Photodetectors and electronic amplifiers have a limited dynamic range, and optimizing the 
separation  is  critical  to  increase  the  levels  of  the  signal  without  saturating  the  detection 
electronics  with  background  intensity.  Using  higher  separations  lead  to  better  signal  to 
background ratios (less sample noise) but at the same time it decreases the intensity of the 
collected  light  leading  to  a  decrease  in  the  system  signal  to  noise  ratio  assuming  fixed 
electronics noise. A compromise has to be made between the signal to background ratio and 
the absolute values of the collected intensity and signal. Our model showed that, for a point 
source, there is an optimal range with high signal levels and high signal to background ratio 
for  both  wavelengths  (735  and  940  nm)  extending  from  0.45  to  1.25  mm.  These  values 
change with the spatial profile of the source. For the case of a 4.5 mm LED, most of this 
plateau phase overlapped with the source and only a peak was seen right next to the source 
followed by a signal decay. Despite this decay, the collected signal is high enough to be 
#147375 - $15.00 USD Received 12 May 2011; revised 27 Jun 2011; accepted 28 Jun 2011; published 29 Jun 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2107detected millimeters away from the source. This was shown in our in vitro data (Fig. 10) 
where changes in oxygenation were still detected 10 mm away from the edge of the source. 
The previously defined SBR ratio showed a similar increasing trend for the  in vitro data. 
However, past 6-8 mm edge to edge separation the ratio showed a decreasing trend that is due 
to the system noise since the total intensity at this point is close to the detection limit of our 
hardware. Note that the same amplification level was used for all separations to provide a fair 
comparison. The numbers for the SBR ratio from the in vitro data are much lower than those 
calculated by the model due to multiple reasons. The main reason for this discrepancy results 
from the use of a simplified 2D layered model with the blood vessel represented as a layer of 
blood.  In  the  real  case,  the  blood  vessel  is  surrounded  by  tissue  that  contributes  to  the 
background intensity and not the oxygenation signal. Also, the dynamic range between the 
optical properties of the two dye mixtures mimicking the two oxygenation states is less than 
that of whole blood which causes a reduction in the signal (S) intensity. However, this second 
factor is not as significant as the first since the optical properties of the dye mixtures at the 
940 nm wavelength match those of whole blood very closely and the reduction in the SBR 
ratio can still be seen. As expected, similar to the modeling results, the product S*SBR also 
showed a decreasing trend for the in vitro data. This shows that the optimal performance of 
this source-detector pair is at the closest separation. 
To better understand this tradeoff between signal levels and the signal to background ratio, 
we ran simulations for different oxygenation levels and observed the correlation between the 
photon fluence values and the oxygenation levels as shown in Figs. 11(a)-(c). For very short  
 
 
Fig. 11. The change in photon fluence at the surface of the tissue with changing oxygenation 
levels. The three panels (a)-(c) correspond to three different source-detector spacings indicated 
in the inset legends. At 0.45 mm separation, the change in diffuse reflection correlates well 
with the oxygenation changes (R
2 = 0.994) and the slope of the linear fit is high (0.00844) 
indicating a good sensitivity to oxygenation changes. Panel (d) shows the changes of the R
2 
factor and the slope as a function of the source to detector separation. 
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2, started as an increasing function and peaked 
at 0.45 mm separation with a peak value of 0.9941. Past this point, R
2 showed a decreasing 
trend and reached 0.9795 (0.7022) at 1.05 mm (10.05 mm) separation. As for the slope of the 
linear fit, it showed a similar trend with increasing source-detector separation as the signal S 
which was expected (Fig. 11(d)). 
The coefficient R
2 shows that, although the slope representing the signal level is highest 
for the shortest separation (Fig. 11(d)), the optimal spacing where the signal correlates best 
with changes in the vessel lumen is at 0.45 mm. This is shown in Figs. 11(a)-(c) where the 
slope and intensity values are the highest in panel (a) (d = 0.15 mm) while the photon fluence 
doesn’t correlate with oxygenation as closely as in the top right panel (d = 0.45 mm). 
Although  the  principle  we  used  in  optimizing  the  source-detector  separation  relies  on 
changing the oxygen saturation of the blood and monitoring its effect on the collected diffuse 
reflectance, the results stand true for any change in the optical properties of the blood whether 
they were due to oxygenation, perfusion or hematocrit variations. 
As mentioned earlier in the introduction, this sensor can be used to monitor perfusion and 
oxygenation in many other visceral organs. Since the optimal source-detector separation is a 
function of the optical properties and the dimensions of the vessel under investigation, the 
results presented in this paper stand true only for the case of the portal vein. However, the 
same methods employed in this manuscript can be used to define the optimal source-detector 
separation for similar applications. 
5. Conclusions 
Source to detector separation is a major factor in optimizing the performance of any diffuse 
reflectance based optical sensor. This becomes more important in the case of implantable 
biosensors where power consumption is of significant concern. In this work, we modeled the 
performance of an implantable perfusion and oxygenation sensor and found a source-detector 
separation of around 0.5 mm to be optimal in the case of a point source. Closer placement of 
the detector yields very high background intensity while moving the detector further than 1.2 
mm shows a rapid decay in total intensity and signal levels. For the more realistic case of a 
4.5 mm diameter LED package and a 2.4 mm x 2.5 mm photodetector, it was shown that the 
highest  signal  is  collected  with  the  source  and  detector  placed  right  next  to  each  other. 
However, similar to the point source case, it was shown that larger separations lead to higher 
SBR. 
The results were compared to data collected from in vitro phantom studies. We reported a 
dye solution  mimicking the absorption properties of the two oxygenation states of blood. 
These mixtures can be useful in characterizing and testing any  optical sensor that probes 
blood. We used these mixtures to perfuse a phantom mimicking the optical and anatomical 
properties of the portal vein and the results were used to verify our modeling data. The in 
vitro data showed similar trends to those of the MC model with some contribution from the 
system/hardware noise that caused the SBR ratio to show a decreasing trend past 6-8 mm 
source-detector separation. 
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